» Articles » PMID: 26621212

Optogenetics-enabled Assessment of Viral Gene and Cell Therapy for Restoration of Cardiac Excitability

Overview
Journal Sci Rep
Specialty Science
Date 2015 Dec 2
PMID 26621212
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple cardiac pathologies are accompanied by loss of tissue excitability, which leads to a range of heart rhythm disorders (arrhythmias). In addition to electronic device therapy (i.e. implantable pacemakers and cardioverter/defibrillators), biological approaches have recently been explored to restore pacemaking ability and to correct conduction slowing in the heart by delivering excitatory ion channels or ion channel agonists. Using optogenetics as a tool to selectively interrogate only cells transduced to produce an exogenous excitatory ion current, we experimentally and computationally quantify the efficiency of such biological approaches in rescuing cardiac excitability as a function of the mode of application (viral gene delivery or cell delivery) and the geometry of the transduced region (focal or spatially-distributed). We demonstrate that for each configuration (delivery mode and spatial pattern), the optical energy needed to excite can be used to predict therapeutic efficiency of excitability restoration. Taken directly, these results can help guide optogenetic interventions for light-based control of cardiac excitation. More generally, our findings can help optimize gene therapy for restoration of cardiac excitability.

Citing Articles

Cardiac optogenetics: shining light on signaling pathways.

Leemann S, Schneider-Warme F, Kleinlogel S Pflugers Arch. 2023; 475(12):1421-1437.

PMID: 38097805 PMC: 10730638. DOI: 10.1007/s00424-023-02892-y.


Study of near-infrared light-induced excitation of upconversion nanoparticles as a vector for non-viral DNA delivery.

Wang J, Chen H, Chuang C, Chen J RSC Adv. 2022; 10(67):41013-41021.

PMID: 35519194 PMC: 9057729. DOI: 10.1039/d0ra05385f.


Optogenetic Stimulation Using Anion Channelrhodopsin (GtACR1) Facilitates Termination of Reentrant Arrhythmias With Low Light Energy Requirements: A Computational Study.

Ochs A, Karathanos T, Trayanova N, Boyle P Front Physiol. 2021; 12:718622.

PMID: 34526912 PMC: 8435849. DOI: 10.3389/fphys.2021.718622.


Integration of Engineered "Spark-Cell" Spheroids for Optical Pacing of Cardiac Tissue.

Chua C, Han J, Li W, Liu W, Entcheva E Front Bioeng Biotechnol. 2021; 9:658594.

PMID: 34222210 PMC: 8249938. DOI: 10.3389/fbioe.2021.658594.


OptoGap is an optogenetics-enabled assay for quantification of cell-cell coupling in multicellular cardiac tissue.

Boyle P, Yu J, Klimas A, Williams J, Trayanova N, Entcheva E Sci Rep. 2021; 11(1):9310.

PMID: 33927252 PMC: 8085001. DOI: 10.1038/s41598-021-88573-1.


References
1.
Jessup M, Greenberg B, Mancini D, Cappola T, Pauly D, Jaski B . Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure. Circulation. 2011; 124(3):304-13. PMC: 5843948. DOI: 10.1161/CIRCULATIONAHA.111.022889. View

2.
Bruegmann T, Malan D, Hesse M, Beiert T, Fuegemann C, Fleischmann B . Optogenetic control of heart muscle in vitro and in vivo. Nat Methods. 2010; 7(11):897-900. DOI: 10.1038/nmeth.1512. View

3.
Jia Z, Valiunas V, Lu Z, Bien H, Liu H, Wang H . Stimulating cardiac muscle by light: cardiac optogenetics by cell delivery. Circ Arrhythm Electrophysiol. 2011; 4(5):753-60. PMC: 3209525. DOI: 10.1161/CIRCEP.111.964247. View

4.
Comtois P, Nattel S . Interactions between cardiac fibrosis spatial pattern and ionic remodeling on electrical wave propagation. Annu Int Conf IEEE Eng Med Biol Soc. 2012; 2011:4669-72. DOI: 10.1109/IEMBS.2011.6091156. View

5.
Tilemann L, Ishikawa K, Weber T, Hajjar R . Gene therapy for heart failure. Circ Res. 2012; 110(5):777-93. PMC: 3594844. DOI: 10.1161/CIRCRESAHA.111.252981. View